The testing on the blood-brain barrier permeability of this product has not been conducted. However, according to the following article, this compound is expected to be capable of crossing the blood-brain barrier: J Lipid Res. 2004 Oct;45(10):1952-7. The publication is titled "Enzyme blockade: a nonradioactive method to determine the absolute rate of cholesterol synthesis in the brain" and can be found under the PMID: 15258193
Wybierz wielkość
| Rozmiar/SKU | Dostępność | Cena netto |
|---|---|---|
5 mg | Przewidywany termin wysyłki01 października 2026zKuehne + Nagel Sp. z o.o. | 998,00 zł |
Informacje o tej pozycji
998,00 zł
Przewidywany termin wysyłki01 października 2026Szczegóły
Quality Segment
description
RTECS - GU7025000
assay
≥95% (HPLC)
form
solid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, desiccated (hygroscopic)
color
white
solubility
DMSO: 20 mg/mL, water: 20 mg/mL
shipped in
ambient
storage temp.
2-8°C
SMILES string
[Cl-].[Cl-].Clc1c(cccc1)CNCC2CCC(CC2)CNCc3c(cccc3)Cl.[H+].[H+]
InChI
1S/C22H28Cl2N2.2ClH/c23-21-7-3-1-5-19(21)15-25-13-17-9-11-18(12-10-17)14-26-16-20-6-2-4-8-22(20)24;;/h1-8,17-18,25-26H,9-16H2;2*1H
InChI key
NRVIEWRSGDDWHP-UHFFFAOYSA-N
General description
Biochem/physiol Actions
7-dehydrocholesterol reductase (δ7-sterol reductase)
Packaging
Preparation Note
Other Notes
Cooper, M.K., et al. 1998. Science280, 1603.
Incardona, J.P., et al. 1998. Development125, 3553.
Moebius, F.F., et al. 1998. Proc. Natl. Acad. Sci. USA95, 1899.
Yoshida, Y. 1985. J. Biochem.98, 1669.
Kraml, M., et al. 1964. Biochem. Biophys. Res. Commun.15, 455.
Legal Information
Disclaimer
1 of 1
Ta pozycja | |||
|---|---|---|---|
| description A cell-permeable amphiphilic diamine that blocks cholesterol biosynthesis and its esterification. | description The CXCR4 Antagonist I, AMD3100, also referenced under CAS 155148-31-5, controls the biological activity of CXCR4. This small molecule/inhibitor is primarily used for Cell Signaling applications. | description InSolution, ≥98%, 50 mM aqueous solution, CXCR4 antagonist I | description InSolution, ≥97%, controls the biological activity of Sonic Hedgehog signaling pathway |
| form solid | form solid | form liquid | form liquid |
| assay ≥95% (HPLC) | assay ≥98% (HPLC) | assay ≥98% (HPLC) | assay ≥95% (HPLC) |
| manufacturer/tradename Calbiochem® | manufacturer/tradename Calbiochem® | manufacturer/tradename Calbiochem® | manufacturer/tradename Calbiochem® |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. −70°C | storage temp. −70°C |
| storage condition OK to freeze, desiccated (hygroscopic) | storage condition protect from light, OK to freeze, desiccated (hygroscopic) | storage condition avoid repeated freeze/thaw cycles, OK to freeze, protect from light | storage condition OK to freeze, protect from light, avoid repeated freeze/thaw cycles, desiccated (hygroscopic) |
Słowo ostrzegawcze
Danger
Kody zagrożeń
Ostrzeżenia
Hazard Classifications
Acute Tox. 3 Oral
Klasa składowania
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
Co się dzieje?
WGK 3
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.
-
Can this inhibitor cross the blood-brain barrier?
1 answer-
Helpful?
-




